First human face allograft: early report

BACKGROUND Extended soft tissue defects of the face are difficult to reconstruct, and autologous tissue transfers usually lead to poor cosmetic and functional outcomes. We judged that composite tissue transplantation could be valuable in facial reconstructive surgery. METHODS We transplanted the central and lower face of a brain-dead woman onto a woman aged 38 years who had suffered amputation of distal nose, both lips, chin, and adjacent parts of the cheeks. Transplantation consisted of revascularisation of right and left facial arteries and veins (ischaemic time 4 h), mucosal repair of oral and nasal vestibules, bilateral anastomoses of infraorbital and mental sensitive nerves, joining of mimic muscles with motor nerve suture on mandibular branch of the left facial nerve, and skin closure. Immunosuppressive treatment was with thymoglobulin, tacrolimus, mycophenolate mofetil, and prednisone. Two infusions of donor bone-marrow cells were given. Follow-up included routine tests, biopsies, physiotherapy, and psychological support. FINDINGS The initial postoperative course was uneventful. No surgical complication occurred. Bone-marrow graft and immunosuppression were well tolerated. Mild clinical signs of rejection were seen at day 20. Increased corticoids initially did not reverse rejection, but signs of rejection disappeared after three boluses of prednisone. Anatomical and psychological integration and recovery of sensation were excellent. At the end of the first postoperative week, the patient could eat, and speech improved quickly. Passive transmission of muscle contractions to the graft already exists; physiotherapy is being done to restore dynamic motions around the lips. INTERPRETATION The 4-month outcome demonstrates the feasibility of this procedure. The functional result will be assessed in the future, but this graft can already be deemed successful with respect to appearance, sensitivity, and acceptance by the patient.

[1]  B. Blomberg,et al.  Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation. , 2003, Transplant immunology.

[2]  G. Malhotra,et al.  Total face and scalp replantation. , 1998, Plastic and reconstructive surgery.

[3]  C. Ricordi,et al.  An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry. , 1996, Transplantation.

[4]  B. Griffith,et al.  A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. , 2000, The Journal of thoracic and cardiovascular surgery.

[5]  J. Zins,et al.  A New Composite Facial and Scalp Transplantation Model in Rats , 2003, Plastic and reconstructive surgery.

[6]  V. Lambros.  What age(s) for face lifts? , 1999, Plastic and reconstructive surgery.

[7]  J. Zins,et al.  New Surgical Approach in Facial Transplantation Extends Survival of Allograft Recipients , 2005, Annals of plastic surgery.

[8]  S. Slavin,et al.  Transplantation of hematopoietic stem cells for induction of unresponsiveness to organ allografts , 2004, Springer Seminars in Immunopathology.

[9]  A. Monaco,et al.  The enigma of tolerance and chimerism: variable role of T cells and chimerism in induction of tolerance with bone marrow. , 2001, Transplantation proceedings.

[10]  E. Schiff,et al.  High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing. , 1997, Transplantation.

[11]  G. Ciancio,et al.  Bone Marrow-Induced Tolerance in the Era of Pancreas and Islets Transplantation , 2006, Pancreas.

[12]  M. Lanzettà,et al.  Human hand allograft: report on first 6 months , 1999, The Lancet.

[13]  S. Testelin,et al.  Total lower lip functional reconstruction with a prefabricated gracilis muscle free flap. , 2004, International journal of oral and maxillofacial surgery.

[14]  M. Siemionow,et al.  Allotransplantation of the face: how close are we? , 2005, Clinics in plastic surgery.

[15]  Marco Lanzetta,et al.  Pathological score for the evaluation of allograft rejection in human hand (composite tissue) allotransplantation. , 2005, European journal of dermatology : EJD.

[16]  Jean Kanitakis,et al.  First human double hand transplantation: efficacy of a conventional immunosuppressive protocol , 2003, Clinical transplantation.

[17]  A. Demetris,et al.  Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation , 1994, The Lancet.

[18]  T. Starzl,et al.  Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients , 1999 .

[19]  D. Orgill,et al.  Flap prefabrication in the head and neck: a 10-year experience. , 1999, Plastic and reconstructive surgery.

[20]  K. Harii,et al.  Tissue Expansion in Facial Reconstruction , 1994, Plastic and reconstructive surgery.

[21]  W. Lee,et al.  First Successful Replantation of Face and Scalp With Single-Artery Repair: Model for Face and Scalp Transplantation , 2003, Annals of plastic surgery.

[22]  C. Ricordi,et al.  The human bone marrow as an immunoregulatory organ. , 1999, Transplantation.

[23]  C. Angrigiani,et al.  Total face reconstruction with one free flap. , 1997 .

[24]  C. Ricordi,et al.  DONOR BONE MARROW-DERIVED CHIMERIC CELLS PRESENT IN RENAL TRANSPLANT RECIPIENTS INFUSED WITH DONOR MARROW. I. POTENT REGULATORS OF RECIPIENT ANTIDONOR IMMUNE RESPONSES1 , 2000, Transplantation.

[25]  L. Téot,et al.  Prefabricated vascularised supraclavicular flaps for face resurfacing after postburns scarring , 2000, The Lancet.

[26]  J. Zins,et al.  Functional tolerance following face transplantation in the rat. , 2003, Transplantation.

[27]  A. Monaco,et al.  Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt. , 1976, Surgery.